Patent · US Active

Substituted piperazines as BTK inhibitors

US11655254B2 · kind B2 · utility

0Cited by

0References

35Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Guangxiu Dai · Shanghai, CN
Kun Xiao · Shanghai, CN

Key dates

Filing date	Apr 25, 2022
Grant date	May 23, 2023
Priority date	—
Expiry date	Apr 25, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are heteroaryl heterocyclic compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the variables are as defined in the description. The compounds are Btk inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.